All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Arcturus Therapeutics Ltd. revenue reports

Arcturus Therapeutics Ltd. financial reports, Arcturus Therapeutics Ltd. annual revenue in 2024. When does Arcturus Therapeutics Ltd. report revenue?
Add to widgets
Added to widgets

Arcturus Therapeutics Ltd. total revenue, net income and dynamics of changes in US dollar today

Arcturus Therapeutics Ltd. net revenue for today is 2 127 000 $. Net income Arcturus Therapeutics Ltd. - -56 346 000 $. Information about net income is used from open sources. The dynamics of Arcturus Therapeutics Ltd. net income went down. The change was -25 242 000 $. The financial graph of Arcturus Therapeutics Ltd. shows the values and changes of such indicators: total assets, net income, net revenue. The financial report chart shows the values from 31/12/2018 to 31/03/2021. The value of the "total revenue of Arcturus Therapeutics Ltd." on the chart is marked in yellow.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 2 127 000 $ -51.103 % ↓ -56 346 000 $ -
31/12/2020 2 238 000 $ -70.463 % ↓ -31 104 000 $ -
30/09/2020 2 333 000 $ -29.687 % ↓ -21 004 000 $ -
30/06/2020 2 322 000 $ -77.13 % ↓ -10 263 000 $ -
30/09/2019 3 318 000 $ - -7 433 000 $ -
30/06/2019 10 153 000 $ - -685 000 $ -
31/03/2019 4 350 000 $ - -6 884 000 $ -
31/12/2018 7 577 000 $ - -1 011 000 $ -
Show:
to

Arcturus Therapeutics Ltd. financial report charts

The dates of the latest financial statements of Arcturus Therapeutics Ltd.: 31/12/2018, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Arcturus Therapeutics Ltd. is 31/03/2021. Gross profit Arcturus Therapeutics Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Arcturus Therapeutics Ltd. is -47 923 000 $

Arcturus Therapeutics Ltd. quarterly report dates

Cost of revenue Arcturus Therapeutics Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Arcturus Therapeutics Ltd. is 50 050 000 $ Total revenue Arcturus Therapeutics Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Arcturus Therapeutics Ltd. is 2 127 000 $ Operating income Arcturus Therapeutics Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Arcturus Therapeutics Ltd. is -57 666 000 $

Net income Arcturus Therapeutics Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Arcturus Therapeutics Ltd. is -56 346 000 $ Current assets Arcturus Therapeutics Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Arcturus Therapeutics Ltd. is 469 996 000 $ Total assets Arcturus Therapeutics Ltd. refers to the total amount of assets owned by a person or entity. Total assets Arcturus Therapeutics Ltd. is 481 468 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-47 923 000 $ -22 048 000 $ -15 366 000 $ -5 622 000 $ -3 735 000 $ 2 884 000 $ -2 974 000 $ 2 730 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
50 050 000 $ 24 286 000 $ 17 699 000 $ 7 944 000 $ 7 053 000 $ 7 269 000 $ 7 324 000 $ 4 847 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
2 127 000 $ 2 238 000 $ 2 333 000 $ 2 322 000 $ 3 318 000 $ 10 153 000 $ 4 350 000 $ 7 577 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 3 318 000 $ 10 153 000 $ 4 350 000 $ 7 577 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-57 666 000 $ -31 082 000 $ -20 938 000 $ -10 042 000 $ -7 616 000 $ -572 000 $ -6 508 000 $ -711 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-56 346 000 $ -31 104 000 $ -21 004 000 $ -10 263 000 $ -7 433 000 $ -685 000 $ -6 884 000 $ -1 011 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - - 7 324 000 $ 7 324 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
59 793 000 $ 33 320 000 $ 23 271 000 $ 12 364 000 $ 10 934 000 $ 10 725 000 $ 10 858 000 $ 8 288 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
469 996 000 $ 467 789 000 $ 314 100 000 $ 142 000 000 $ 79 408 000 $ 63 338 000 $ 36 606 000 $ 41 828 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
481 468 000 $ 476 456 000 $ 322 520 000 $ 149 935 000 $ 87 215 000 $ 70 940 000 $ 44 419 000 $ 44 198 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
466 839 000 $ 462 895 000 $ 307 023 000 $ 136 111 000 $ 74 172 000 $ 55 840 000 $ 31 220 000 $ 36 709 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 21 688 000 $ 16 414 000 $ 14 612 000 $ 12 577 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 51 320 000 $ 49 322 000 $ 38 065 000 $ 30 556 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 58.84 % 69.53 % 85.70 % 69.13 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
352 607 000 $ 396 553 000 $ 261 630 000 $ 93 423 000 $ 35 895 000 $ 21 618 000 $ 6 354 000 $ 13 642 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -2 836 000 $ 9 340 000 $ -5 411 000 $ -5 763 000 $

Last revenue report of Arcturus Therapeutics Ltd. was 31/03/2021. According to last financial report total revenue in Arcturus Therapeutics Ltd. was 2 127 000 US dollar and changed by -51.103% since last year. Net income in Arcturus Therapeutics Ltd. was -56 346 000 $ in last quartal, net income changes to 0%.

Current cash Arcturus Therapeutics Ltd. - the sum of all of the cash a company has on the date of report. Current cash Arcturus Therapeutics Ltd. is 466 839 000 $

Arcturus Therapeutics Ltd. stocks data

Arcturus Therapeutics Ltd. financials